Huashan Hospital

This is an early safety study testing a new type of personalized cell therapy called C-CAR168. It is for adults with severe autoimmune diseases of the brain and nervous system, like multiple sclerosis, that have not improved with standard treatments. The main goals are to see if …

This is an early, exploratory study to test the safety and initial effectiveness of a new therapy called GC012F for people with multiple sclerosis (MS). The therapy involves collecting a patient's own immune cells, modifying them in a lab to potentially target MS, and then infusi…

This study is testing whether adding one or two new drugs (orelabrutinib and teniposide) to standard chemotherapy works better for newly diagnosed primary brain lymphoma. Researchers will randomly assign 215 adults to receive different drug combinations to see which helps more pa…

This study is testing whether a new type of PET scan (called 18F-AGX PET) can detect early signs of how well the drug Vorasidenib is working in adults with a specific, recurring type of slow-growing brain tumor. The goal is to see if changes on this special scan happen before cha…